Supernus Pharm (SUPN) Misses Q1 Loss Views
Tweet
Share
E-mailGet Alerts SUPN Hot Sheet
Join SI Premium – FREE
Supernus Pharm (NASDAQ: SUPN) reported Q1 EPS of ($1.51), $0.02 worse than the analyst estimate of ($1.49).
After adjustment for a 4-for-1 reverse split, the first-quarter loss was $6.05 per share.
For earnings history and earnings-related data on Supernus Pharm (SUPN) click here.
After adjustment for a 4-for-1 reverse split, the first-quarter loss was $6.05 per share.
For earnings history and earnings-related data on Supernus Pharm (SUPN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Chubb Corp. (CB) Tops Q1 EPS by 10c
- EQT Corp. (EQT) Tops Q1 EPS by 17c; offers outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
